David Paul Hansemann: chromosomes and the origin of the cancerous features of tumor cells.
作者信息
Bignold Leon P, Coghlan Brian, Jersmann Hubertus
出版信息
Cell Oncol. 2009;31(1):61. doi: 10.3233/clo-2009-0451.
Abstract
摘要
相似文献
1
David Paul Hansemann: chromosomes and the origin of the cancerous features of tumor cells.大卫·保罗·汉斯曼：染色体与肿瘤细胞癌变特征的起源
Cell Oncol. 2009;31(1):61. doi: 10.3233/clo-2009-0451.
2
Reappraisal of the Hansemann-Boveri hypothesis on the origin of tumors.对汉斯曼-博韦里肿瘤起源假说的重新评估。
Cell Biol Int. 2005 Dec;29(12):983-92. doi: 10.1016/j.cellbi.2005.10.001. Epub 2005 Nov 28.
3
Hansemann, Boveri, chromosomes and the gametogenesis-related theories of tumours.
Cell Biol Int. 2006 Jul;30(7):640-4. doi: 10.1016/j.cellbi.2006.04.002. Epub 2006 Apr 25.
4
JMM---past and present. Chromosomes and cancer: Theodor Boveri's predictions 100 years later.《医学分子微生物学》——过去与现在。染色体与癌症：西奥多·博韦里百年后的预言
J Mol Med (Berl). 2002 Sep;80(9):545-8. doi: 10.1007/s00109-002-0374-y. Epub 2002 Aug 22.
5
["He corrects my view and develops it further." Comments by David von Hansemann on the monograph by Theodor Boveri Concerning the origin of malignant tumors (1914)].["他纠正了我的观点并使其进一步发展。" 大卫·冯·汉斯曼对西奥多·博韦里关于恶性肿瘤起源的专著的评论（1914年）]
Ber Wiss. 2011 Sep;34(3):263-83. doi: 10.1002/bewi.201101505.
6
Brief historical sketch of chromosomal translocations and tumors.染色体易位与肿瘤的简要历史概述。
J Natl Cancer Inst Monogr. 2008(39):2-7. doi: 10.1093/jncimonographs/lgn013.
7
Early references to the mutational origin of cancer.早期关于癌症突变起源的论述。
Int J Epidemiol. 2007 Feb;36(1):246-7. doi: 10.1093/ije/dyl272. Epub 2006 Dec 14.
8
Studying human chromosomes today.
Am Sci. 1970 Mar-Apr;58(2):182-201.
9
The history of cytogenetics. Portraits of some pioneers.细胞遗传学的历史。一些先驱者的画像。
Ann Genet. 2003 Oct-Dec;46(4):433-42. doi: 10.1016/s0003-3995(03)00012-1.
10
Janet Davison Rowley, M.D. (1925–2013).珍妮特·戴维森·罗利医学博士（1925 - 2013）。
Am J Hum Genet. 2014 Jun 5;94(6):805-8. doi: 10.1016/j.ajhg.2014.05.008.
引用本文的文献
1
Tumor differentiation impacts response to neoadjuvant therapy and survival in patients with esophageal adenocarcinoma.肿瘤分化影响食管腺癌患者对新辅助治疗的反应和生存。
J Thorac Cardiovasc Surg. 2024 Jun;167(6):1943-1950. doi: 10.1016/j.jtcvs.2023.09.055. Epub 2023 Oct 1.
2
Leveraging single-cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers.利用单细胞测序技术揭示人类癌症中的肿瘤内异质性和肿瘤进化。
J Pathol. 2022 Jul;257(4):466-478. doi: 10.1002/path.5914. Epub 2022 May 23.
3
Prognostic value of DNA aneuploidy in gastric cancer: a meta-analysis of 3449 cases.胃癌中 DNA 非整倍体的预后价值：3449 例病例的荟萃分析。
BMC Cancer. 2019 Jul 2;19(1):650. doi: 10.1186/s12885-019-5869-9.
4
The dualistic origin of human tumors.人类肿瘤的二元起源。
Semin Cancer Biol. 2018 Dec;53:1-16. doi: 10.1016/j.semcancer.2018.07.004. Epub 2018 Jul 21.
5
High ubiquitin-specific protease 44 expression induces DNA aneuploidy and provides independent prognostic information in gastric cancer.高泛素特异性蛋白酶 44 表达诱导胃癌 DNA 非整倍体并提供独立的预后信息。
Cancer Med. 2017 Jun;6(6):1453-1464. doi: 10.1002/cam4.1090. Epub 2017 May 23.
6
Clinical application of DNA ploidy to cervical cancer screening: A review.DNA倍体在宫颈癌筛查中的临床应用：综述
World J Clin Oncol. 2014 Dec 10;5(5):931-65. doi: 10.5306/wjco.v5.i5.931.
7
Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers.胃癌中 DNA 非整倍体的临床特征和分子机制。
J Gastroenterol. 2012 Apr;47(4):351-8. doi: 10.1007/s00535-012-0565-4. Epub 2012 Mar 9.
8
High expression of BUBR1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer.BUBR1 的高表达是导致胃癌中 DNA 非整倍体和进展的因素之一。
Cancer Sci. 2010 Mar;101(3):639-45. doi: 10.1111/j.1349-7006.2009.01457.x. Epub 2009 Dec 4.
Zotero 插件